__________

Neu­ro­science used to be the monop­oly of a few elite uni­ver­si­ties locat­ed in a hand­ful of coun­tries. Neu­ropsy­chol­o­gy used to be a quaint niche dis­ci­pline rel­a­tive­ly uncon­nect­ed to the larg­er world of neu­ro­science and con­tent in its meth­ods with paper-and-pen­cil tests. Read the rest of this entry »

—–

BrainCheck rais­es $3 mil­lion for app to mon­i­tor brain health (TechCrunch):

“A Hous­ton-based start­up called BrainCheck has raised $3 mil­lion in seed fund­ing for an app that helps users under­stand, by sim­ply play­ing some games on an iPad, if they or a loved one may have suf­fered a con­cus­sion. Read the rest of this entry »

Accord­ing to a new posi­tion state­ment by the Amer­i­can Acad­e­my of Neu­rol­o­gy (AAN), pre­scrib­ing cog­ni­tive enhance­ment, “atten­tion-boost­ing,” drugs to healthy chil­dren is mis­guid­ed and not jus­ti­fi­able. Inter­est­ing­ly, a 2009 posi­tion state­ment by AAN still in force today stat­ed that doing so with adult “patients” is both legal and eth­i­cal (includ­ing the remark that “Neu­rol­o­gists who pre­scribe med­ica­tions for the off-label use of neu­roen­hance­ment are act­ing law­ful­ly,” with­out real­ly chal­leng­ing whether the drugs have been proven to be a) effec­tive and b) safe in that con­text). Read the rest of this entry »